Ashurst has advised Australian Pharmaceutical Industries Limited on the deal. API, Wesfarmers and Wesfarmers Limited (Wesfarmers Parent) has entered into a Scheme Implementation Deed (SID), pursuant...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here